Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism
Li Yang,Yiqi Gong,Yao Tan,Lei Wu,Nevin Witman,Jijian Zheng,Jun Zhang,Wei Fu,Wei Wang
DOI: https://doi.org/10.21037/atm-20-5898
IF: 3.616
2021-03-01
Annals of Translational Medicine
Abstract:BACKGROUND: Ventricular-like human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) exhibit the electrophysiological characteristics of spontaneous beating. Previous studies demonstrated that dexmedetomidine (DMED), a highly selective and widely used α<sub>2</sub>-adrenoceptor agonist for sedation, analgesia, and stress management, may induce antiarrhythmic effects, especially ventricular tachycardia. However, the underlying mechanisms of the DMED-mediated antiarrhythmic effects remain to be fully elucidated.METHODS: A conventional patch-clamp recording method was used to investigate the direct effects of DMED on spontaneous action potentials, pacemaker currents (<i>I</i> <sub>f</sub>), potassium (K<sup>+</sup>) channel currents (<i>I</i> <sub>K1</sub> and <i>I</i> <sub>Kr</sub>), sodium (Na<sup>+</sup>) channel currents (<i>I</i> <sub>Na</sub>), and calcium (Ca<sup>2+</sup>) channel currents (<i>I</i> <sub>Ca</sub>) in ventricular-like hiPSC-CMs.RESULTS: DMED dose-dependently altered the frequency of ventricular-like spontaneous action potentials with a half-maximal inhibitory concentration (IC<sub>50</sub>) of 27.9 µM (n=6) and significantly prolonged the action potential duration at 90% repolarization (APD<sub>90</sub>). DMED also inhibited the amplitudes of the <i>I</i> <sub>Na</sub> and <i>I</i> <sub>Ca</sub> without affecting the activation and inactivation curves of these channels. DMED decreased the time constant of the Na<sup>+</sup> and Ca<sup>2+</sup> channel activation at potential -40 to -20 mv, and -20 mv. DMED increased the time constant of inactivation of the Na<sup>+</sup> and Ca<sup>2+</sup> channels. However, DMED did not affect the <i>I</i> <sub>K1</sub>, <i>I</i> <sub>Kr</sub>, <i>I</i> <sub>f</sub>, and their current-voltage relationship. The ability of DMED to decrease the spontaneous action potential frequency and the Na<sup>+</sup> and Ca<sup>2+</sup> channel amplitudes, were not blocked by yohimbine, idazoxan, or phentolamine.CONCLUSIONS: DMED could inhibit the frequency of spontaneous action potentials and decrease the <i>I</i> <sub>Na</sub> and <i>I</i> <sub>Ca</sub> of hiPSC-CMs via mechanisms that were independent of the α<sub>2</sub>-adrenoceptor, the imidazoline receptor, and the α<sub>1</sub>-adrenoceptor. These inhibitory effects on hiPSC-CMs may contribute to the antiarrhythmic effects of DMED.
oncology,medicine, research & experimental